ARCHIVES

Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable

This article is from The Cancer Letter archive.

Vol. 37 No. 17 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile

November 30, 2012

DCT Issues Two Pas for Small/Exploratory Grants For Clinical, Laboratory Studies

March 23, 1994

First Clinical Guidelines On Ductal Lavage Published

March 29, 2002

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

DeVita Considers Laetrile Tests

June 3, 1977

Patient Care Emerges as Major Concern Following Sequestration Cuts to Medicare

April 5, 2013